Wighteone, a prenylated flavonoid from licorice, inhibits growth of SW480 colorectal cancer cells by allosteric inhibition of Akt

被引:5
作者
Chen, Xiaofei [1 ]
Ma, Ruili [1 ]
Wu, Weiguo [1 ]
Gao, Ran [1 ]
Shu, Yikang [1 ]
Dong, Mingxin [2 ]
Guo, Mengzhe [1 ]
Tang, Daoquan [1 ]
Li, Danhua [3 ]
Ji, Shuai [1 ]
机构
[1] Xuzhou Med Univ, Sch Pharm, Jiangsu Key Lab New Drug Res & Clin Pharm, Xuzhou 221004, Peoples R China
[2] Guangdong Pharmaceut Univ, Sch Pharm, Guangzhou 510640, Peoples R China
[3] Xuzhou Med Univ, Dept Pathol, Lab Clin & Expt Pathol, Xuzhou 221004, Peoples R China
关键词
Wighteone; Colorectal cancer; Akt; Allosteric inhibition; Licorice;
D O I
10.1016/j.jep.2024.118195
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Licorice is a frequently used herbal medicine worldwide, and is used to treat cough, hepatitis, cancer and influenza in clinical practice of traditional Chinese medicine. Modern pharmacological studies indicate that prenylated flavonoids play an important role in the anti -tumor activity of licorice, especially the tumors in stomach, lung, colon and liver. Wighteone is one of the main prenylated flavonoids in licorice, and its possible effect and target against colorectal cancer have not been investigated. Aim of the study: This study aimed to investigate the anti -colorectal cancer effect and underlying mechanism of wighteone. Materials and methods: SW480 human colorectal cancer cells were used to evaluate the in vitro anti -colorectal cancer activity and Akt regulation effect of wighteone by flow cytometry, phosphoproteomic and Western blot analysis. Surface plasmon resonance (SPR) assay, molecular docking and dynamics simulation, and kinase activity assay were used to investigate the direct interaction between wighteone and Akt. A nude mouse xenograft model with SW480 cells was used to verify the in vivo anti -colorectal cancer activity of wighteone. Results: Wighteone inhibited phosphorylation of Akt and its downstream kinases in SW480 cells, which led to a reduction in cell viability. Wighteone had direct interaction with both PH and kinase domains of Akt, which locked Akt in a " closed " conformation with allosteric inhibition, and Gln79, Tyr272, Arg273 and Lys297 played the most critical role due to their hydrogen bond and hydrophobic interactions with wighteone. Based on Akt overexpression or activation in SW480 cells, further mechanistic studies suggested that wighteone-induced Akt inhibition led to cycle arrest, apoptosis and autophagic death of SW480 cells. Moreover, wighteone exerted in vivo anti -colorectal cancer effect and Akt inhibition activity in the nude mouse xenograft model. Conclusion: Wighteone could inhibit growth of SW480 cells through allosteric inhibition of Akt, which led to cell cycle arrest, apoptosis and autophagic death. The results contributed to understanding of the anti -tumor mechanism of licorice, and also provided a rationale to design novel Akt allosteric inhibitors for the treatment of colorectal cancer.
引用
收藏
页数:13
相关论文
共 34 条
[1]   Cell survival and metastasis regulation by Akt signaling in colorectal cancer [J].
Agarwal, Ekta ;
Brattain, Michael G. ;
Chowdhury, Sanjib .
CELLULAR SIGNALLING, 2013, 25 (08) :1711-1719
[2]   Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma [J].
Al-Saffar, Nada M. S. ;
Troy, Helen ;
Te Fong, Anne-Christine Wong ;
Paravati, Roberta ;
Jackson, L. Elizabeth ;
Gowan, Sharon ;
Bouit, Jessica K. R. ;
Robinson, Simon P. ;
Eccles, Suzanne A. ;
Yap, Timothy A. ;
Leach, Martin O. ;
Chung, Yuen-Li .
BRITISH JOURNAL OF CANCER, 2018, 119 (09) :1118-1128
[3]   Maximising the potential of MKT inhibitors as anti-cancer treatments [J].
Brown, Jessica S. ;
Banerji, Udai .
PHARMACOLOGY & THERAPEUTICS, 2017, 172 :101-115
[4]  
Commission C.P., 2020, Pharmacopoeia of the People's Republic of China
[5]   Licorice: Resources, applications in ancient and modern times [J].
Ding, Yiming ;
Brand, Eric ;
Wang, Wenquan ;
Zhao, Zhongzhen .
JOURNAL OF ETHNOPHARMACOLOGY, 2022, 298
[6]   Discovery of Inter-Domain Stabilizers-A Novel Assay System for Allosteric Akt Inhibitors [J].
Fang, Zhizhou ;
Simard, Jeffrey R. ;
Plenker, Dennis ;
Nguyen, Hoang D. ;
Trang Phan ;
Wolle, Patrik ;
Baumeister, Stefan ;
Rauh, Daniel .
ACS CHEMICAL BIOLOGY, 2015, 10 (01) :279-288
[7]   p53 Regulation of the IGF-1/AKT/mTOR Pathways and the Endosomal Compartment [J].
Feng, Zhaohui .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (02) :a001057
[8]   Comparative analysis of compound NSC13728 as Omomyc homodimer stabilizer by molecular dynamics simulation and MM/GBSA free energy calculation [J].
Gao, Jian ;
Wang, Yinchuan ;
Li, Kaihang ;
Zhang, Jinyuan ;
Geng, Xiaoju .
JOURNAL OF MOLECULAR MODELING, 2022, 28 (04)
[9]   PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer [J].
Glaviano, Antonino ;
Foo, Aaron S. C. ;
Lam, Hiu Y. ;
Yap, Kenneth C. H. ;
Jacot, William ;
Jones, Robert H. ;
Eng, Huiyan ;
Nair, Madhumathy G. ;
Makvandi, Pooyan ;
Geoerger, Birgit ;
Kulke, Matthew H. ;
Baird, Richard D. ;
Prabhu, Jyothi S. ;
Carbone, Daniela ;
Pecoraro, Camilla ;
Teh, Daniel B. L. ;
Sethi, Gautam ;
Cavalieri, Vincenzo ;
Lin, Kevin H. ;
Javidi-Sharifi, Nathalie R. ;
Toska, Eneda ;
Davids, Matthew S. ;
Brown, Jennifer R. ;
Diana, Patrizia ;
Stebbing, Justin ;
Fruman, David A. ;
Kumar, Alan P. .
MOLECULAR CANCER, 2023, 22 (01)
[10]   An updated patent review of Akt inhibitors (2016-present) [J].
Guo, Yu ;
Jin, Yizhen ;
Qu, Bingxue ;
Zhang, Yu ;
Che, Jinxin ;
Dong, Xiaowu .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2021, 31 (09) :837-849